Research Findings #44: Retail Drug Prices, Out-of-Pocket Costs, and Discounts and Markups Relative to List Prices: Trends and Differences by Drug Type and Insurance Status, 2011 to 2016

Research Findings #44: Retail Drug Prices, Out-of-Pocket Costs, and Discounts and Markups Relative to List Prices: Trends and Differences by Drug Type and Insurance Status, 2011 to 2016

AHRQ Stats: Brand-Name and Generic Drugs

From 2011 to 2016, the share of filled prescriptions that were nonspecialty, single-source, brand-name drugs decreased from 22 to 11 percent while nonspecialty generic equivalents increased from 72 to 83 percent. (Source: AHRQ, Medical Expenditure Panel Survey Research Findings #44: Retail Drug Prices, Out-of-Pocket Costs, and Discounts and Markups Relative to List Prices: Trends and Differences by Drug Type and Insurance Status, 2011 to 2016.)